ARMP - Armata Pharmaceuticals, Inc.
8.37
-0.980 -11.708%
Share volume: 27,065
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$9.35
-0.98
-0.10%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-13-2024 | 11-13-2024 | 03-21-2025 | 05-14-2025 | 08-12-2025 | 11-12-2025 | 03-25-2026 | |
| Total revenue | 966.000 K | 0.000 | 2.973 M | 1.235 M | 491.000 K | 2.169 M | 1.159 M | 1.085 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 966.000 K | 0.000 | 2.973 M | 1.235 M | 491.000 K | 2.169 M | 1.159 M | 1.085 M | |
| -100.00% | inf% | -58.46% | -60.24% | 341.75% | -46.57% | -6.38% | |||
| Operating expenses | 11.194 M | 11.914 M | 12.729 M | 11.773 M | 8.682 M | 9.013 M | 8.935 M | 9.496 M | |
| Selling general and admin | 3.178 M | 3.439 M | 3.244 M | 3.323 M | 3.253 M | 2.619 M | 3.111 M | 3.426 M | |
| Research and development | 8.016 M | 8.475 M | 9.485 M | 8.450 M | 5.429 M | 6.394 M | 5.824 M | 6.070 M | |
| Total expenses | 11.194 M | 11.914 M | 12.729 M | 11.773 M | 8.682 M | 9.013 M | 8.935 M | 14.908 M | |
| 6.43% | 6.84% | -7.51% | -26.25% | 3.81% | -0.87% | 66.85% | |||
| Operating income | -10.228 M | -11.914 M | -9.756 M | -10.538 M | -8.191 M | -6.844 M | -7.776 M | -13.823 M | |
| Ebit | -23.253 M | 11.483 M | -5.481 M | -3.831 M | -6.531 M | -16.295 M | -26.675 M | -124.298 M | |
| Pretax income | -25.021 M | 8.986 M | -5.481 M | 2.600 M | -6.531 M | -16.295 M | -26.675 M | -124.298 M | |
| -135.91% | -160.99% | -147.44% | -351.19% | 149.50% | 63.70% | 365.97% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -25.021 M | 8.986 M | -5.481 M | 2.600 M | -6.531 M | -16.295 M | -26.675 M | -124.298 M | |
| 135.91% | -160.99% | 147.44% | -351.19% | -149.50% | -63.70% | -365.97% |